A defined medium and substrate for expansion of human mesenchymal stromal cell progenitors that enriches for osteo- and chondrogenic precursors

Stem Cells and Development

Volumn 20, Issue 1, 2011, Pages 77-87

  Hudson, James E ^a   Mills, Richard J ^a   Frith, Jessica E ^a   Brooke, Gary ^b   Jaramillo Ferrada, Pamela ^a   Wolvetang, Ernst J ^a   Cooper White, Justin J ^a  

^a UNIVERSITY OF QUEENSLAND   (Australia)

^b MATER MEDICAL RESEARCH INSTITUTE   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

5' NUCLEOTIDASE; ACTIVATED LEUKOCYTE CELL ADHESION MOLECULE; ALPHA1 INTEGRIN; BETA1 INTEGRIN; BOVINE SERUM ALBUMIN; CD146 ANTIGEN; CD34 ANTIGEN; CD45 ANTIGEN; CELL SURFACE MARKER; ENDOGLIN; HERMES ANTIGEN; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; THY 1 ANTIGEN; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR B9; TRANSCRIPTION FACTOR RUNX2; UNCLASSIFIED DRUG;

ADIPOGENESIS; ADULT; ARTICLE; BONE CELL; CELL COUNT; CELL DIFFERENTIATION; CELL GROWTH; CELL LINEAGE; CONTROLLED STUDY; DOWN REGULATION; EMBRYONIC STEM CELL; GENE EXPRESSION; HUMAN; HUMAN CELL; MESENCHYMAL STEM CELL; PRIORITY JOURNAL; STEM CELL EXPANSION; UPREGULATION;

ADOLESCENT; ADULT; ANIMALS; ANTIGENS, SURFACE; CATTLE; CELL DIFFERENTIATION; CELL LINEAGE; CELL PROLIFERATION; CELL SHAPE; CHONDROGENESIS; COLONY-FORMING UNITS ASSAY; CULTURE MEDIA; EXTRACELLULAR MATRIX; FLOW CYTOMETRY; GENE EXPRESSION REGULATION; HUMANS; MESENCHYMAL STEM CELLS; OSTEOGENESIS; RNA, MESSENGER; STROMAL CELLS; TISSUE DONORS; TRANSCRIPTION FACTORS; YOUNG ADULT;

BOVINAE;

EID: 78650985995     PISSN: 15473287     EISSN: None     Source Type: Journal    
DOI: 10.1089/scd.2009.0497     Document Type: Article

References (47)

1. Brooke G, M Cook, C Blair, R Han, C Heazlewood, B Jones, M Kambouris, K Kollar, S McTaggart, R Pelekanos, A Rice, T Rossetti and K Atkinson. (2007). Therapeutic applications of mesenchymal stromal cells. Semin Cell Dev Biol 18:846-858.
2. Pittenger MF, AM Mackay, SC Beck, RK Jaiswal, R Douglas, JD Mosca, MA Moorman, DW Simonetti, S Craig and DR Marshak. (1999). Multilineage potential of adult human mesenchymal stem cells. Science 284:143-147.
3. Ren G, L Zhang, X Zhao, G Xu, Y Zhang, AI Roberts, RC Zhao and Y Shi. (2008). Mesenchymal stem cell-mediated immunosuppression occurs via concerted action of chemokines and nitric oxide cell. Stem Cell 2:141-150.
4. Maitra B, E Szekely, K Gjini, MJ Laughlin, J Dennis, SE Haynesworth and ON Koc. (2004). Human mesenchymal stem cells support unrelated donor hematopoietic stem cells and suppress T-cell activation. Bone Marrow Transplant 33:597-604.
5. Segers VFM and RT Lee. (2008). Stem-cell therapy for cardiac disease. Nature 451:937-942.
6. Murry CE, LJ Field and P Menasche. (2005). Cell-based cardiac repair: reflections at the 10-year point. Circulation 112:3174-3183.
7. Le Blanc K, H Samuelsson, B Gustafsson, M Remberger, B Sundberg, J Arvidson, P Ljungman, H Lonnies, S Nava and O Ringden. (2007). Transplantation of mesenchymal stem cells to enhance engraftment of hematopoietic stem cells. Leukemia 21:1733-1738.
8. Koc ON, SL Gerson, BW Cooper, SM Dyhouse, SE Haynesworth, AI Caplan and HM Lazarus. (2000). Rapid hematopoietic recovery after coinfusion of autologous-blood stem cells and culture-expanded marrow mesenchymal stem cells in advanced breast cancer patients receiving high-dose chemotherapy. J Clin Oncol 18:307-316.
9. Covas DT, RA Panepucci, AM Fontes, WA Silva Jr., MD Orellana, MCC Freitas, L Neder, ARD Santos, LC Peres, MC Jamur and MA Zago. (2008). Multipotent mesenchymal stromal cells obtained from diverse human tissues share functional properties and gene-expression profile with CD146 perivascular cells and fibroblasts. Exp Hematol 36:642-654.
10. Schallmoser K, E Rohde, A Reinisch, C Bartmann, D Thaler, C Drexler, AC Obenauf, G Lanzer, W Linkesch and D Strunk. (2008). Rapid large-scale expansion of functional mesenchymal stem cells from unmanipulated bone marrow without animal serum. Tissue Eng Part C Methods 14:185-196.
11. Sakamoto N, K Tsuji, LM Muul, AM Lawler, EF Petricoin, F Candotti, JA Metcalf, JA Tavel, HC Lane, WJ Urba, BA Fox, A Varki, JK Lunney and AS Rosenberg. (2007). Bovine apolipoprotein B-100 is a dominant immunogen in therapeutic cell populations cultured in fetal calf serum in mice and humans. Blood 110:501-508.
12. Sundin M, O Ringden, B Sundberg, S Nava, C Gotherstrom and K Le Blanc. (2007). No alloantibodies against mesenchymal stromal cells, but presence of anti-fetal calf serum antibodies, after transplantation in allogeneic hematopoietic stem cell recipients. Haematologica 92:1208-1215.
13. Selvaggi TA, RE Walker and TA Fleisher. (1997). Development of antibodies to fetal calf serum with arthus-like reactions in human immunodeficiency virus-infected patients given syngeneic lymphocyte infusions. Blood 89:776-779.
14. Capelli C, M Domenghini, G Borleri, P Bellavita, R Poma, A Carobbio, C Mico, A Rambaldi, J Golay and M Introna. (2007). Human platelet lysate allows expansion and clinical grade production of mesenchymal stromal cells from small samples of bone marrow aspirates or marrow filter washouts. Bone Marrow Transplant 40:785-791.
15. Doucet C, I Ernou, Y Zhang, J-R Llense, L Begot, X Holy and J-J Lataillade. (2005). Platelet lysates promote mesenchymal stem cell expansion: a safety substitute for animal serum in cell-based therapy applications. J Cell Physiol 205:228-236.
16. Lange C, F Cakiroglu, A-N Spiess, H Cappallo-Obermann, J Dierlamm and AR Zander. (2007). Accelerated and safe expansion of human mesenchymal stromal cells in animal serum-free medium for transplantation and regenerative medicine. J Cell Physiol 213:18-26.
17. Schallmoser K, C Bartmann, E Rohde, A Reinisch, K Kashofer, E Stadelmeyer, C Drexler, G Lanzer, W Linkesch and D Strunk. (2007). Human platelet lysate can replace fetal bovine serum for clinical-scale expansion of functional mesenchymal stromal cells. Transfusion 47:1436-1446.
18. Kocaoemer A, S Kern, H Klüter and K Bieback. (2007). Human AB serum and thrombin-activated platelet-rich plasma are suitable alternatives to fetal calf serum for the expansion of mesenchymal stem cells from adipose tissue. Stem Cells 25:1270-1278.
19. Turnovcova K, K Ruzickova, V Vanecek, E Sykova and P Jendelova. (2009). Properties and growth of human bone marrow mesenchymal stromal cells cultivated in different media. Cytotherapy 11:874-885.
20. Gronthos S and PJ Simmons. (1995). The growth factor requirements of STRO-1-positive human bone marrow stromal precursors under serum-deprived conditions in vitro. Blood 85:929-940.
21. Apel A, A Groth, S Schlesinger, H Bruns, P Schemmer, MW Büchler and I Herr. (2009). Suitability of human mesenchymal stem cells for gene therapy depends on the expansion medium. Exp Cell Res 315:498-507.
22. Ng F, S Boucher, S Koh, KSR Sastry, L Chase, U Lakshmipathy, C Choong, Z Yang, MC Vemuri, MS Rao and V Tanavde. (2008). PDGF, TGF-{beta}, and FGF signaling is important for differentiation and growth of mesenchymal stem cells (MSCs): transcriptional profiling can identify markers and signaling pathways important in differentiation of MSCs into adipogenic, chondrogenic, and osteogenic lineages. Blood 112:295-307.
23. Battula VL, PM Bareiss, S Treml, S Conrad, I Albert, S Hojak, H Abele, B Schewe, L Just, T Skutella and H-J Bühring. (2007). Human placenta and bone marrow derived MSC cultured in serum-free, b-FGF-containing medium express cell surface frizzled-9 and SSEA-4 and give rise to multilineage differentiation. Differentiation 75:279-291.
24. Bianchi G, A Banfi, M Mastrogiacomo, R Notaro, L Luzzatto, R Cancedda and R Quarto. (2003). Ex vivo enrichment of mesenchymal cell progenitors by fibroblast growth factor 2. Exp Cell Res 287:98-105.
25. Martin I, A Muraglia, G Campanile, R Cancedda and R Quarto. (1997). Fibroblast growth factor-2 supports ex vivo expansion and maintenance of osteogenic precursors from human bone marrow. Endocrinology 138:4456-4462.
26. Muraglia A, R Cancedda and R Quarto. (2000). Clonal mesenchymal progenitors from human bone marrow differentiate in vitro according to a hierarchical model. J Cell Sci 113:1161-1166.
27. Zaragosi L-E, G Ailhaud and C Dani. (2006). Autocrine fibroblast growth factor 2 signaling is critical for self-renewal of human multipotent adipose-derived stem cells. Stem Cells 24:2412-2419.
28. Solchaga LA, K Penick, JD Porter, VM Goldberg, AI Caplan and JF Welter. (2005). FGF-2 enhances the mitotic and chondrogenic potentials of human adult bone marrowderived mesenchymal stem cells. J Cell Physiol 203:398-409.
29. Ludwig TE, ME Levenstein, JM Jones, WT Berggren, ER Mitchen, JL Frane, LJ Crandall, CA Daigh, KR Conard, MS Piekarczyk, RA Llanas and JA Thomson. (2006). Derivation of human embryonic stem cells in defined conditions. Nat Biotechnol 24:185-187.
30. Ludwig TE, V Bergendahl, ME Levenstein, J Yu, MD Probasco and JA Thomson. (2006). Feeder-independent culture of human embryonic stem cells. Nat Methods 3:637-646.
31. Song L, NE Webb, Y Song and RS Tuan. (2006). Identification and functional analysis of candidate genes regulating mesenchymal stem cell self-renewal and multipotency. Stem Cells 24:1707-1718.
32. Neth P, M Ciccarella, V Egea, J Hoelters, M Jochum and C Ries. (2006). Wnt signaling regulates the invasion capacity of human mesenchymal stem cells. Stem Cells 24:1892-1903.
33. Etheridge SL, GJ Spencer, DJ Heath and PG Genever. (2004). Expression profiling and functional analysis of wnt signaling mechanisms in mesenchymal stem cells. Stem Cells 22:849-860.
34. Wang L, TC Schulz, ES Sherrer, DS Dauphin, S Shin, AM Nelson, CB Ware, M Zhan, C-Z Song, X Chen, SN Brimble, A McLean, MJ Galeano, EW Uhl, KA DAmour, JD Chesnut, MS Rao, CA Blau and AJ Robins. (2007). Self-renewal of human embryonic stem cells requires insulin-like growth factor-1 receptor and ERBB2 receptor signaling. Blood 110:4111-4119.
35. Schubert D and H Kimura. (1991). Substratum-growth factor collaborations are required for the mitogenic activities of activin and FGF on embryonal carcinoma cells. J Cell Biol 114:841-846.
36. Gronthos S, PJ Simmons, SE Graves and PG Robey. (2001). Integrin-mediated interactions between human bone marrow stromal precursor cells and the extracellular matrix. Bone 28:174-181.
37. Gronthos S, ACW Zannettino, SJ Hay, S Shi, SE Graves, A Kortesidis and PJ Simmons. (2003). Molecular and cellular characterisation of highly purified stromal stem cells derived from human bone marrow. J Cell Sci 116(Pt 9):1827-1835.
38. Simmons PJ and B Torok-Storb. (1991). Identification of stromal cell precursors in human bone marrow by a novel monoclonal antibody, STRO-1. Blood 78:55-62.
39. Rider D, T Nalathamby, V Nurcombe and S Cool. (2007). Selection using the alpha-1 integrin (CD49a) enhances the multipotentiality of the mesenchymal stem cell population from heterogeneous bone marrow stromal cells. J Mol Histol 38:449-458.
40. Gang EJ, D Bosnakovski, CA Figueiredo, JW Visser and RCR Perlingeiro. (2007). SSEA-4 identifies mesenchymal stem cells from bone marrow. Blood 109:1743-1751.
41. Taipale J and J Keski-Oja. (1997). Growth factors in the extracellular matrix. FASEB J 11:51-59.
42. Zhou G, Q Zheng, F Engin, E Munivez, Y Chen, E Sebald, D Krakow and B Lee. (2006). Dominance of SOX9 function over RUNX2 during skeletogenesis. Proc Natl Acad Sci USA 103:19004-19009.
43. Jaquiéry C, S Schaeren, J Farhadi, P Mainil-Varlet, C Kunz, H-F Zeilhofer, M Heberer and I Martin. (2005). In vitro osteogenic differentiation and in vivo bone-forming capacity of human isogenic jaw periosteal cells and bone marrow stromal cells. Ann Surg 242:859-868.
44. Bianco P, SA Kuznetsov, M Riminucci, P Gehron Robey. (2006). Postnatal skeletal stem cells. In: Methods in Enzymology. Klimanskaya I, R Lanza, eds. Academic Press, San Diego, CA pp 117-148.
45. Martin I, et al. (2001). Quantitative analysis of gene expression in human articular cartilage from normal and osteoarthritic joints. Osteoarthritis Cartilage 9:112-118.
46. Selvamurugan N, S Kwok and NC Partridge. (2004). Smad3 Interacts with JunB and Cbfa1=Runx2 for transforming growth factor-Î1-stimulated collagenase-3 expression in human breast cancer cells. J Biol Chem 279:27764-27773.
47. Frith JE, B Thomson and P Genever. (2009). Dynamic threedimensional culture methods enhance mesenchymal stem cell properties and increase therapeutic potential. Tissue Eng Part C Methods [Epub ahead of print].